These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 4764148)
1. [Vitiligo in patients with porphyria]. Guseinov MM Vestn Dermatol Venerol; 1973 Jun; 47(6):11-4. PubMed ID: 4764148 [No Abstract] [Full Text] [Related]
2. [Problems and prospects of vitiligo study]. Koshevenko IuN; Frolov EP Vestn Dermatol Venerol; 1981; (10):25-30. PubMed ID: 6272508 [No Abstract] [Full Text] [Related]
3. The protective role of epidermal melanin in a patient with porphyria variegata and vitiligo. Westerhof W; Bebelaar D; Cormane RH; Langelaar J; Hup JM Acta Derm Venereol; 1981; 61(1):23-8. PubMed ID: 6164210 [TBL] [Abstract][Full Text] [Related]
4. [Current points of view on the therapy of vitiligo]. Ormea F Minerva Med; 1974 Apr; 65(30):1653-64. PubMed ID: 4833771 [No Abstract] [Full Text] [Related]
5. Histopathologic features in vitiligo. Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112 [TBL] [Abstract][Full Text] [Related]
6. [DNA synthesis in melanocytes during vitiligo]. Tschernosemski I; Petkov I; Durmischev A; Zlatkov NB Dermatol Monatsschr; 1978 Mar; 164(3):180-5. PubMed ID: 658568 [No Abstract] [Full Text] [Related]
7. Melanocytes are not absent in lesional skin of long duration vitiligo. Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216 [TBL] [Abstract][Full Text] [Related]
8. On the etiology of vitiligo and gray hair. Lerner AB Am J Med; 1971 Aug; 51(2):141-7. PubMed ID: 5095523 [No Abstract] [Full Text] [Related]
10. The effect of acetylsalicylic acid on the release rates of leukotrienes B4 and C4 from cultured skin melanocytes of active vitiligo. Zailaie MZ Saudi Med J; 2004 Oct; 25(10):1439-44. PubMed ID: 15494818 [TBL] [Abstract][Full Text] [Related]
11. Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo. Kingo K; Aunin E; Karelson M; Rätsep R; Silm H; Vasar E; Kõks S J Dermatol Sci; 2008 Oct; 52(1):39-46. PubMed ID: 18514490 [TBL] [Abstract][Full Text] [Related]
12. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133 [TBL] [Abstract][Full Text] [Related]
13. Aberrant Notch signaling: a potential pathomechanism of vitiligo. Diao JS; Zhang X; Xia WS; Zheng Y; Ren J; Wang YM; Gong Z; Xia W; Guo SZ Med Hypotheses; 2009 Jul; 73(1):70-2. PubMed ID: 19269111 [TBL] [Abstract][Full Text] [Related]
14. A holistic review on the autoimmune disease vitiligo with emphasis on the causal factors. Patel S; Rauf A; Khan H; Meher BR; Hassan SSU Biomed Pharmacother; 2017 Aug; 92():501-508. PubMed ID: 28575807 [TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis and treatment of vitiligo]. Borisenko KK Vestn Dermatol Venerol; 1973 May; 47(5):11-6. PubMed ID: 4755955 [No Abstract] [Full Text] [Related]